Taken together, these results indicate that the USP7 inhibitor p22077 may modulate cardiac remodeling by targeting and stabilizing a series of substrate proteins, which play important roles cardiac hypertrophy, fibrosis, inflammation, oxidase stress, and the progression of heart failure (Figure 7). The gene discussed is USP7; the disease is cardiac hypertrophy.